Azribi, Fathi
Abdou, Ehab
Dawoud, Emad
Ashour, Mohamed
Kamal, Amgad
Al Sayed, Mohamed
Burney, Ikram
Article History
Received: 17 June 2021
Accepted: 23 November 2021
First Online: 20 December 2021
Declarations
:
: The study was approved by the local ethics committee of Ministry of Health, Kuwait (Ref No. 1990), Sultan Qaboos University (SQUH), Oman (Ref No. MREC # 1441), and Tawam Hospital, UAE (Ref No. SA/SS/600). Patients enrolled in this study signed an informed consent form (ICF) when meeting all inclusion criteria.
: Not applicable.
: Amgad Kamal and Mohamed Alsayed work for AstraZeneca; however, there is no conflict of interest. Dr. Fathi Azribi has received honoraria for Advisory board, as a speaker and travel, from AstraZeneca, Pfizer, Novartis, BMS, Amgen, and MSD. The rest of the authors declare that they have no conflict of interest.